Sicagen India (BOM:533014) Other Stockholders Equity: ₹4,554 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:533014 Sicagen India Ltd BOM:533014
72 GF Score
Price ₹51.50
GF Value ₹73.51
Valuation Significantly Undervalued
! 2 Warning Signs
View Full Analysis

What is Sicagen India Other Stockholders Equity?

Sicagen India BOM:533014 +5.51% 72 Other Stockholders Equity is ₹4,554 Mil as of Mar. 2026. GuruFocus rates BOM:533014 with a GF Score™ of 72/100 and a GF Value™ of ₹73.51 (Significantly Undervalued). The stock has 2 warning signs investors should review.

Sicagen India's Other Stockholders Equity for the quarter that ended in Mar. 2026 was ₹4,554 Mil.

Sicagen India's quarterly Other Stockholders Equity declined from Sep. 2025 (₹4,784 Mil) to Dec. 2025 (₹0 Mil) but then increased from Dec. 2025 (₹0 Mil) to Mar. 2026 (₹4,554 Mil).

Sicagen India's annual Other Stockholders Equity increased from Mar. 2024 (₹1,458 Mil) to Mar. 2025 (₹1,547 Mil) and increased from Mar. 2025 (₹1,547 Mil) to Mar. 2026 (₹4,554 Mil).

Sicagen India Other Stockholders Equity Historical Data

* Premium members only.

The historical data trend for Sicagen India's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sicagen India Other Stockholders Equity Chart

Sicagen India Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Other Stockholders Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,402.60 1,417.40 1,458.30 1,547.30 4,554.40

Sicagen India Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,547.30 0.00 4,784.20 0.00 4,554.40
BOM:533014
72GF Score
Sicagen India Ltd BOM:533014
Other Stockholders Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sicagen India Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

What does a Other Stockholders Equity of ₹4,554 Mil mean?
Sicagen India (BOM:533014) has a Other Stockholders Equity of ₹4,554 Mil as of Mar. 2026. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Sicagen India and its competitors.
Is Sicagen India's Other Stockholders Equity too high?
Sicagen India's current Other Stockholders Equity is ₹4,554 Mil. Overall, Sicagen India has a GF Score™ of 72/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Sicagen India's Other Stockholders Equity compare to NUE and STLD?
Sicagen India's Other Stockholders Equity of ₹4,554 Mil can be compared against companies in the Steel industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Stockholders Equity for a Steel company?
A good Other Stockholders Equity depends on the Steel industry context. However, Other Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Stockholders Equity mean?
A high Other Stockholders Equity can signal that a stock is expensive relative to its fundamentals. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Sicagen India and its competitors. Sicagen India's current Other Stockholders Equity is ₹4,554 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sicagen India stock overvalued right now?
Based on GuruFocus' analysis, Sicagen India (BOM:533014) is currently considered Significantly Undervalued. The stock's GF Value™ is ₹73.51, compared to a current price of ₹51.50 — trading 29.9% below its estimated fair value. The current Other Stockholders Equity is ₹4,554 Mil. Sicagen India's overall GF Score™ is 72/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Stockholders Equity calculated?
Other Stockholders Equity is calculated from a company's financial statements. For Sicagen India (BOM:533014), the current Other Stockholders Equity is ₹4,554 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Sicagen India (BOM:533014) Overvalued in 2026?

Based on GuruFocus' analysis, Sicagen India stock appears to be undervalued. The current stock price of ₹51.50 is trading 29.9% below its estimated GF Value™ of ₹73.51. GuruFocus considers Sicagen India to be Significantly Undervalued.

Key valuation signals for BOM:533014:

  • Other Stockholders Equity: ₹4,554 Mil
  • GF Value™: ₹73.51 vs. price of ₹51.50 (29.9% below fair value)
  • GF Score™: 72/100 with 2 warning signs

No single metric tells the full story. See the BOM:533014 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Sicagen India Business Description

Other Exchanges SICAGEN:India
Address No. 88, Mount Road, 4th Floor, SPIC House, Guindy, Chennai, TN, IND, 600 032
Sicagen India Ltd is an investment holding company. Its principal business lines are building materials, power and control systems, manufacturing of MS barrels and manufacturing of water treatment chemicals, industrial packaging, speciality chemicals, engineering, cable manufacturing, and fabrication. It serves a diverse range of markets including retail, institutional, dealers, corporate, builders, agriculturists, fabricators, and contractors. The company's segment includes Trading and Manufacturing. It generates maximum revenue from the Trading segment from India.
72GF Score

Get the complete analysis for BOM:533014

Other Stockholders Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹51.50
Price
₹73.51
GF Value